170 related articles for article (PubMed ID: 36097872)
1. Sodium-glucose cotransporter 2 inhibitors for heart failure with mildly reduced or preserved ejection fraction: time to deliver implementation.
Greene SJ; Fonarow GC; Butler J
Eur J Heart Fail; 2022 Oct; 24(10):1902-1905. PubMed ID: 36097872
[No Abstract] [Full Text] [Related]
2. Implementing Sodium-Glucose Cotransporter-2 Inhibitor Therapy for Heart Failure: What Is the Message to DELIVER?
Nassif ME; Januzzi JL
J Am Coll Cardiol; 2022 Nov; 80(19):1785-1787. PubMed ID: 36328689
[No Abstract] [Full Text] [Related]
3. Obese or lean: Whom to prescribe sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction?
Halavina K; Bartko PE; Nitsche C
Eur J Heart Fail; 2024 Apr; 26(4):910-911. PubMed ID: 38679836
[No Abstract] [Full Text] [Related]
4. [Sodium-glucose cotransporter 2 inhibitors for the management of heart failure].
Nouel A; Winter JL; Sepúlveda L
Rev Med Chil; 2022 Dec; 150(12):1647-1654. PubMed ID: 37906786
[TBL] [
